獨協医科大学 · 埼玉医療センター：糖尿病内分泌・血液内科 · 糖尿病内分泌・血液内科 病院准教授

研究关键词type 2 diabetes・oral semaglutide・hemoglobin A1c interference・telemedicine diabetes care・skin autofluorescence・SGLT2 inhibitors・GLP-1 physiology

以下为公开数据预览。个性化匹配理由、联系角度和保存能力需要登录后使用。

• Analysis of five cases showing false-high Hemoglobin A1c due to reduced catalase activity., Hara K, Ujiie A, Suzuki S, Okumura T, Kubo M, Shinozaki H, Yamauchi M, Tsuchiya T, Takebayashi K, Shimozawa N, Koga M, Hashimoto K, Endocr J, 71, 39-44, 2024年2024 · 論文
• Effects of telemedicine on the management of diabetes mellitus in the COVID-19 pandemic- A single center study-., Furukawa S, Kawai S, Yamauchi M, Shinozaki H, Ujiie A, Okumura T, Kubo M, Suzuki S, Asai K, Takii H, Hara K, Miyakawa K, Hara K, Tsuchiya T, Takebayashi K, Hashimoto K, Dokkyo Med J, 2023年2023 · 論文
• Changing from a Dipeptidyl Peptidase (DPP)-4 Inhibitor to Oral Semaglutide in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Observational Study., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Medical J., 2（Jun）, 123-129, 2023年2023 · 論文
• Switching from a dipeptidyl peptidase (DPP)-4 inhibitor to oral semaglutide in patients with poorly controlled type 2 diabetes: an observational study., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., 2022年2022 · 論文

• 官方个人主页